US › Healthcare

Sanara Medtech Inc (SMTI)

US · Healthcare · Medical Instruments & Supplies

$33.16-5.50%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$28.1M

Revenue YoY

+8.9%

Net profit

$-452,864

EPS

$0.05

EPS estimate

$0.02

Net margin

-1.6%

EPS came in at 0.05 against a street estimate of 0.02 — a beat of 150.0%.

Key statistics

Market cap

$322.2M

Forward P/E

217.4

P/B

40.66

Book value

$0.86

EPS (TTM)

$-0.04

52-week high

$35.34

52-week low

$16.05

50-day MA

$34.69

200-day MA

$24.77

Beta

1.19

Analyst view

Analysts rate Sanara Medtech Inc a hold (0 buy, 3 hold, 0 sell out of 3) with an average price target of $35.00.

Shareholding

Insiders

47.94%

Institutions

18.61%

Largest institutional holders

Fund	Stake
BlackRock Inc	2.71%
Vanguard Capital Management, LLC	2.12%
Royal Bank of Canada	1.43%
Stonebridge Wealth Management, LLC	1.41%
AQR Capital Management LLC	1.22%
Geode Capital Management, LLC	0.97%
The Goldman Sachs Group Inc	0.81%
Renaissance Technologies Corp	0.73%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sanara Medtech Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.